Coronavirus Update: Moderna’s COVID-19 Vaccine Passes First Test In Elderly Patients

Encouraging Results From Phase I Study

 
• By Scrip Team

Plus: Korea approves Celltrion antibody trial in mild patients, promising signs for Translate Bio's mRNA candidate in animal studies.

Elderly_Vaccination
The results show older people respond as well as younger individuals, generating antibodies 2-3 times higher than seen in convalescent sera

More from COVID-19

More from Scrip